Table 5 Clinical data and laboratory tests on patients with HRS categorized according to changes in serum sodium concentration
Characteristics | Non-decreased (n = 24) | Decreased (n = 4) | p value |
|---|---|---|---|
Age | 53.75 ± 10.97 | 65.50 ± 4.93 | 0.006 |
Sex | 0.508 | ||
Male (%) | 21 (87.5) | 3 (75.0) | |
Female (%) | 3 (12.5) | 1(25.0) | |
Etiology of cirrhosis | 0.436 | ||
Alcoholics (%) | 13 (54.2) | 3 (75.0) | |
Non-alcoholics (%) | 11 (45.8) | 1 (25.0) | |
Infusion of albumin | 0.436 | ||
Yes (%) | 13 (54.2) | 3 (75.0) | |
No (%) | 11 (45.8) | 1 (25.0) | |
Cumulative dose of Terlipressin (mg) | 18.21 ± 5.92 | 20.25 ± 7.41 | 0.541 |
Amount of hydration (L) | 3.87 ± 2.45 | 5.28 ± 3.21 | 0.317 |
Amount of sodium infused (mEq) | 245.18 ± 242.31 | 207.10 ± 240.77 | 0.773 |
Total bilirubin (0 ~ 1.2 mg/dL) | 16.39 ± 11.97 | 12.50 ± 9.93 | 0.545 |
Albumin (3.4 ~ 4.8 g/dL) | 2.63 ± 0.45 | 2.68 ± 0.46 | 0.824 |
Creatinine (0.6 ~ 1.2 mg/dL) | 3.61 ± 2.39 | 2.94 ± 1.56 | 0.617 |
Hemoglobin (13 ~ 17 g/dL) | 10.53 ± 1.95 | 8.40 ± 1.12 | 0.045 |
*PT(0.8 ~ 1.2 *INR) | 1.91 ± 0.63 | 2.88 ± 1.15 | 0.190 |
*MELD score | 32.92 ± 8.87 | 35.50 ± 10.08 | 0.600 |
*MELD-Na | 46.38 ± 15.72 | 32.25 ± 17.86 | 0.114 |
Child-Pugh score (6 ~ 18) | 10 .79 ± 1.79 | 13.00 ± 0.81 | 0.003 |
Initial sodium (135 ~ 145 mmol/L) | 126.50 ± 7.78 | 137.12 ± 5.11 | 0.014 |
Lowest sodium (135 ~ 145 mmol/L) | 126.69 ± 7.44 | 126.98 ± 5.43 | 0.943 |